Medicinal cannabis: recent changes and future innovations

Callum McGuinn

Callum McGuinn
18 Jun 2019

Government policy on the prescription of cannabis-derived medicines has undergone some interesting and important changes over the past few months, both.

Protecting the ‘Trojan horse’ drug key to keeping a struggling field viable

Sarah Kostiuk-Smith

Sarah Kostiuk-Smith
20 May 2019

An Expert View.

Dosage regimen patents: bruised but not beaten

Julie Carlisle

Julie Carlisle
28 Mar 2019

Ruling on the big pharma Actavis v ICOS case, the UK Supreme Court has found ICOS’s Cialis patent to be invalid for obviousness.

Playing for time: strategies that can help extend a drug's patent life

Emily Hayes

Emily Hayes
25 Mar 2019

In our new magazine Forward, we interview C Hunter Baker of Wolf, Greenfield & Sacks PC.  Hunter explores a typical drug development timeline and.

Eight key themes from the J.P. Morgan Healthcare Conference

Sean Jauss

Sean Jauss
14 Jan 2019

I’ve spent the last few days talking with biotech entrepreneurs, VC fund managers and lawyers attending the 37th Annual J.P. Morgan Healthcare.

The importance of Innovation Hubs in the UK's North West Region

Anna Mudge

Anna Mudge
02 Dec 2018

Life science ‘start-ups’, ‘spin-outs’ and SMEs are some of the most innovative businesses and are often based upon truly great technology and ideas..

Supreme Court decision signals bad news for patent holders

Nick Sutcliffe

Nick Sutcliffe
14 Nov 2018

The UK Supreme Court issued its decision today on the Warner Lambert vs Generics (UK) Ltd t/a Mylan. The decision concerns Swiss-form patent claims.

Development in the war on superbugs

Matthew Smith

Matthew Smith
29 Oct 2018

The spread of antibiotic-resistant infections is one of the most serious threats in modern medicine. Fuelled by the overuse of existing medicines, the.